Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: We need to lower health risks in SEZs

Susann Roth, senior social development specialist, Asian Development Bank, gives one way how health risks can be lowered at Special Economic Zones.

Many countries in developing Asia are establishing Special Economic Zones (SEZs) to offer an attractive investment climate for the private sector and to foster industrial and economic development outside of major cities. Across the Greater Mekong Subregion (GMS) there are over 500 SEZs and industrial estates, many of which have been strategically located along or near the 11 GMS economic corridors. The aim is to create what is called a “seamless production zone” within the subregion.

One major development impact of SEZs is job creation. In the GMS alone, SEZs are estimated to have already provided employment for millions. Also, as SEZs are often situated in less developed areas, investing in infrastructure is a must. Infrastructure development, in turn, gives nearby communities better access to jobs and services, so SEZs and their surroundings soon become growth engines.

But SEZ development can come at a price in terms of health: environmental degradation and waste management; air pollution; and illness, injury and disease. Another health risk stems from social disruption from changes in lifestyle. This affects people who move to new communities leaving close family and friends behind, threatening their sense of community and belonging – all important factors in a person’s health and wellbeing.

To mitigate these potential negative health impacts and harness the benefits of SEZs as development engines, GMS countries need support and tools. One of those tools is a proposed Health Impact Assessment (HIA) framework for SEZs, which has been developed by ADB in consultation with country experts.

An HIA is a well-established evidence-based method of calculating the costs of infrastructure projects to human health and to the health sector in general, and assess how the health co-benefits of such projects can be maximised. It considers how community health is affected by changes in the environmental and social determinants. Assessing the health impact of SEZs should foster public health management plans to address the social determinants of health (living conditions and environment) as well as access to health services.

Within the GMS, each country organizes and manages its SEZs in a different way. For instance, some are purely managed by the private sector and others through public-private sector collaboration. Also, HIA policies and guidelines differ slightly in each country. This has prompted the need to develop an overarching HIA framework that is flexible so it can be applied to meet the context for each country.

A common HIA framework for all GMS countries should be a priority for SEZ development, since only a healthy workforce and community is a productive one. This approach also leverages the private sector to invest in the health of its workers, since the implementation of a SEZ-wide public health management plan requires public-private collaboration to ensure good health for SEZ workers.

The framework aims to provide enhanced guidance for identifying, mitigating, and managing health risks and impacts related to the unprecedented industrial and economic development at and around SEZs in GMS countries. It seeks to address cross-border health issues associated with mobile/migrant worker populations.

Cross-border health issues include transmission of vector-borne diseases like malaria and dengue, which we can only aspire to prevent with proper cross-border surveillance and response. Likewise, cross-border referral and health financing systems would support seamless health care for communities in border areas.

HIA can deliver benefits for businesses involved in an SEZ and for communities affected by it. The framework places people directly affected by or associated with SEZ development at the centre of health planning, by prioritising their health and wellbeing in the SEZ’s associated facilities and activities.

Finally, the HIA process needs to be responsive to the pace of SEZ development. As SEZs change and grow, new businesses will emerge, and demographics will change over time. This can create different and new health risks that HIA and public health management plans must tackle.

Investing in HIA at SEZs not only mitigates the potential negative health impacts of economic development, but also enhances health benefits. Ultimately it improves health service delivery to people in and around SEZs, while fostering public-private collaboration. It’s a vision that acknowledges that good health at SEZs is not the responsibility of one, but of all.

Posted on: 28/02/2018 UTC+08:00


News

China Isotope & Radiation, which manufactures diagnostic and therapeutic radiopharmaceuticals products, has launched its HK$1.9 billion (US$247 million) IPO on the Hong Kong Stock Exchange.
Malaysian multinational PRG Holdings has extended the deadline for its M$18.3 million (US$4.6 million) acquisition of O&G focused private medical services provider Roopi Medical Centre.
Hong Kong-listed WuXi Biologics, a subsidiary of WuXi PharmaTech, has started the construction of an integrated biologics conjugate solution centre in Wuxi city.
RHT Health Trust, the first business trust listed on the Singapore stock exchange with a portfolio comprising healthcare assets in India, has confirmed that it has received all outstanding amounts due from India’s Fortis Healthcare for the past financial year.
Shares in Ramsay Health Care, Australia’s largest private hospital operator, slumped today after the group cut earnings guidance. It flagged up “onerous lease provisions” and asset writedowns on a number of its hospitals in the UK.
Following Monday’s 5.9 magnitude earthquake which struck Osaka, Parkway Life REIT, which is owned by IHH Healthcare, has confirmed that its Japan asset managers, operators and residents at its Japan healthcare facilities are accounted for with no reported injuries.
Singapore-listed property developer Perennial Real Estate has incorporated a new subsidiary in China. Perennial (Shanghai) Health Management will be involved in the management of its healthcare business in Shanghai.
Yestar Aesthetic Medical Group, the second largest private aesthetic medical institution group in China, is planning an IPO on Hong Kong’s mainboard. CICC is sole sponsor to the deal.



Analysis

Aon’s inaugural Asia Healthcare Trends Report 2017/18 shows that although Hong Kong has a lower medical inflation rate than the average in APAC, it is the highest in Greater China.
Out of date and unsecure fax machines are still being used to share patient information between healthcare providers in Australia. Not only do fax machines cause frustration for healthcare providers trying to communicate with each other, they can also cause patient harm.
Health and well-being programmes are fragmented and do not meet the needs of stressed Asia workforces, finds Willis Towers Watson. By and large, employers in Asia still miss the mark when it comes to their health and well-being benefits, with many employees feeling that their needs are not met, according to research from the global advisory, broking and solutions company.
According to a survey of biopharma companies by L.E.K. Consulting, the majority of firms from Western Europe or the US are interested in China, specifically those at Phase 2 or later development.
Sara Jost, global healthcare industry lead at BlackBerry, explains that putting the systems and procedures in place to deliver a healthy and secure digital healthcare system will protect patient health information and support medical innovation.
Joseph Soon, global digital director at Bupa, explains why industry players must stay agile in the market and act fast to take every opportunity the digital age has to offer.
The Asia-Pacific (APAC) healthcare industry is undergoing rapid transformation with a dramatic shift in consumer behaviour and expectations, opening up growth opportunities across diagnostics, regenerative medicine, medical tourism and digital health.
Tan Chorh Chuan, executive director at the Office for Healthcare Transformation and chief health scientist at the Ministry of Health in Singapore, explains why population health improvement has to become a crucial area of focus.
my images

Podcasts

HealthInvestor Asia twitter feed